Table 2a.
Regression Findings for Within-Subject Analyses on Multiscale Entropy for Subjects receiving Coffea cruda
| Stage 3 | Stage 4 | |||||||
|---|---|---|---|---|---|---|---|---|
| REM Cycle 1 | REM Cycle 2 | REM Cycle 1 | REM Cycle 2 | |||||
| Electrode Site | Remedy Night | Post-Remedy Change | Remedy Night | Post-Remedy Change | Remedy Night | Post-Remedy Change | Remedy Night | Post-Remedy Change |
| C3 | .54(.42) | −.52(.59) | .69(.44) | −1.3(.62)* | .55(.43) | −.11(.61) | .74(.4) † | −.97(.68) |
| C4 | .47(.44) | −.42(.6) | .44(.46) | −1.4(.53)* | .89(.38)* | −.74(.54) | .87(.32)** | −1.7(.62)** |
| CZ | .98(.35)** | −1(.49)* | .69(.49) | −1.5(.51)** | .67(.39) † | −.49(.52) | .95(.38)* | −1.5(.62)* |
| PZ | .57(.4) | −.33(.56) | 1.1(.46)* | −1.8(.55)** | .83(.42)* | −.66(.56) | .8(.41)* | −1.4(.59)* |
| O1 | .63(.42) | −.53(.61) | .72(.52) | −1.2(.66) † | .03(.44) | .41(.51) | .9(.25)*** | −1.1(.53)* |
| O2 | .61(.4) | −.43(.65) | .97(.46)* | −1.4(.54)* | .84(.35)* | −.55(.5) | .79(.31)* | −1.6(.63)* |
†
P<0.10,
*
P<0.05,
**
P<0.01,
***
P<0.001.
Reported effects are unstandardized beta coefficients and standard error (in parentheses) for each of the two REM cycles of remedy night (night 22) and the change from night 22 to post-remedy night 23, after controlling for personality, baseline nights, placebo night, and change from placebo to post-placebo night.